• A
  • |
  • A
  • Text size

Reports by topic

Council name change

To more fully reflect the scope of the issues it addresses, the name of the Council on Scientific Affairs (CSA) was changed in June 2005 to the Council on Science and Public Health (CSAPH).

Council reports from 1994 through the 2005 AMA Annual Meeting are posted as CSA reports and those posted from the June 2006 AMA Annual Meeting on are posted as CSAPH reports.

AIDS/HIV
Air travel: medical considerations
Alcohol/nicotine/other drug abuse

Use of Electronic Cigarettes in Smoking Cessation (A-10) Full Text

Improving Medical Practice and Patient/Family Education to Reverse the Epidemic of Nonmedical Prescription Drug Use and Addiction (I-08) Summary

Substance Use and Substance Use Disorders (A-08) Summary

AMA Policy on Smoke-free Environments and Workplaces (I-07) Full text

Responding to Depression, Suicide, Substance Use, and Addiction on College Campuses (A-06) Summary

Dextromethorphan Abuse (I-04) Full text

AMA Policy Consolidation: Labeling, Advertising, and Promotion of Alcoholic Beverages (A-04) Full text

Consolidation of AMA Policy on Tobacco and Smoking (A-04) Full text

Effects of Alcohol on the Brains of Underaged Drinkers (A-03) Summary

Hormone Abuse by Adolescents (A-03) Summary

Consensus Statement of the Physician Leadership on National Drug Policy (I-99) Summary, CSA Rep. 9

Screening and Brief Interventions for Alcohol Problems (I-99) Summary, CSA Rep. 14

Reducing Illness and Death Caused by Cigarettes by Reducing Their Nicotine Content (A-98) Summary, CSA Rep. 9

Drivers Impaired by Alcohol (A-97) Summary, CSA Rep. 14

Update: Reduction of the Medical and Public Health Consequences of Drug Abuse (A-99) Summary, CSA Rep. 12

Reduction of the Medical and Public Health Consequences of Drug Abuse (A-97) Summary, CSA Rep. 8

Alcoholism and Alcohol Abuse Among Women (I-97) Summary, CSA Rep. 5

Substance Abuse Among Physicians (A-95) Summary, CSA Rep. 1

Methadone Maintenance in Private Practice (I-94) Summary, CSA Rep. 2

Alternative medicine/folk medicine

See also Race/ethnicity

Alternative Medicine (A-97) CSA, Rep. 12

Folk Remedies Among Ethnic Subgroups (A-97) Summary, CSA Rep. 13

Alternative Therapies for the Symptoms of Menopause (I-96) Summary, CSA, Rep. 4

American Medical Association
Antibiotics/antimicrobials
Asthma
Athletics/sports/recreational injuries/hazards
Bioterrorism/terrorism/disaster preparedness
Blood
Bovine spongiform encephalopathy
Calcium, supplementation
Cancer
Children/adolescent health

Use of Atypical Antipsychotics in Pediatric Patients (I-12) Full text

Ensuring the Best In-school Care for Children With Diabetes (A-08) Full text

Update on Youth and School Violence (I-07) Full text

Emotional and Behavioral Effects of Video Games and Internet Overuse (A-07) Full text

Attention Deficit Hyperactivity Disorder (A-07) Full text

Childhood Anaphylactic Reactions (A-07) Summary

Resources to Combat Teen and Young Adult Suicide in the United States (I-06) Full text

Safety and Efficacy of Serotonin Reuptake Inhibitors (SSRIs) in Children and Adolescents (A-05) Full text

Factors That Influence Differences in Breastfeeding Rates (A-05) Full text

Effects of Alcohol on the Brains of Underaged Drinkers (A-03) Summary

Childhood Asthma: Emerging Patterns and Prospects for Novel Therapies (A-02) Full text

Bullying Behaviors Among Children and Adolescents (A-02) Full text

Newborn Screening: Challenges for the Coming Decade (I-01) Summary

Evaluation of the Federal Abstinence-only Education Programs (A-00) Full text

Sexuality Education, Abstinence, and Distribution of Condoms in Schools (I-99)

School Violence (I-99) Full text

Seclusion and Restraint of Children and Adolescents (A-99) (PDF, Summary, CSA Rep. 10)

Neonatal Circumcision (I-99) Full text

Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder in School-age Children (A-97) (PDF, Summary, CSA Rep. 5)

Bonding Programs for Women Prisoners and their Newborn Children (I-97) Full text

Impact of 24-Hour Postpartum Stay on Infant and Maternal Health (A-95) Full text

Lead Poisoning Among Children (I-94) Full text

Circumcision

Neonatal Circumcision (I-99) Full text

Clinical research
Cloning

See also Genetics

Cloning and Stem Cell Research (A-03) Full text

 

Contraception
Diabetes
Disaster Preparedness - see Bioterrorism

See Bioterrorism/terrorism/disaster preparedness

Discharge criteria
Disparities in health care
Driving
Drugs (Rx/OTC/investigational/regulation)

See also Antibiotics/antimicrobials

A Contemporary View of National Drug Control Policy (I-13) Summary Only

Pharmacy Compounding (A-13) Full Text

National Drug Shortages:  Update (A-13) Full Text

Drug Shortages Update (I-12) Full Text

Risk Evaluation and Mitigation Strategies (I-12)

Drug Shortages Update (A-12) Full Text

An Abbreviated Approval Pathway for Biosimilars (I-11) Full Text

National Drug Shortages (Res 504-A-11) Full Text

Evolving Culture of Drug Safety in the US:  Risk Evaluation and Mitigation Strategies (REMS) (A-10) Full Text

Improving Medical Practice and Patient/Family Education to Reverse the Epidemic of Nonmedical Prescription Drug Use and Addiction (I-08) Summary

Financing of Adult Vaccines:  Recommendations for Action (I-08) Summary

Use of Serotonin Reuptake Inhibitors (SRIs) in Pregnancy (A-07) Full text

Generic Substitution of Narrow Therapeutic Index Drugs (A-07) Full text

Enhanced Physician Access to FDA Data (A-05) Full text

Safety and Efficacy of Serotonin Reuptake Inhibitors (SSRIs) in Children and Adolescents (A-05) Full text

Dextromethorphan Abuse (I-04) Full text

Influence of Funding Source on Outcome, Validity, and Reliability of Pharmaceutical Research (A-04) Full text

Impact of Drug Formularies and Therapeutic Interchange on Health Outcomes (A-04) Full text

The Role of Color Coding in Medication Error Reduction (A-04) Full text

Generic Drugs (A-02) Full text

Improving the Quality of Geriatric Pharmacology (A-02) Full text

Marketing and Clinical Use of Inhaled Nitric Oxide (I-01) Full text

Medical Marijuana (A-01) Full text

Pharmaceutical Expiration Dates (A-01) Full text

Drug Interactions Between Oral Contraceptives and Antibiotics (A-00)

Labeling of Prescription Drug Containers for Generic-substituted Drugs ( I-99) Full text

Safety in Dispensing Prescriptions (A-98) Full text

Use of Opioids in Chronic Nonmalignant Pain (A-99) (Summary, CSA Rep. 11)

Physician Education of Their Patients About Prescription Medicines (I-98) Full text

Unlabeled Indications of FDA-approved Drugs (A-97) (Summary, CSA Rep. 3)

Medical Marijuana (I-97) Full text

Recycling of Nursing Home Drugs (I-97) Full text

National Drug Shortages--Update (A-14) Full text

Biosimilar Product Approval and Marketing (A-14) Summary only

Elderly, health care of
Environmental hazards/issues
Folic acid, supplementation
Food safety - see Nutrition/food safety

See Nutrition/food safety

Genetics
Genetically modified crops and foods
Health promotion/healthy lifestyles
Hearing loss/deficit
Infectious diseases
Mammography
Marijuana

Medical Marijuana (I-09) Full Text

Medical Marijuana (A-01) Full text

Medical Marijuana (I-97) Full text

Mental health
Mercury
Methadone
Mobile
Neurology
Nutrition/food safety
Obesity
Organ or tissue donation/transplantation
Osteoporosis
Pain
Patient(s): health care/education/safety
Physician Health
Pregnancy
Prevention: disease/exposure/hazard
Public health
Race/ethnicity
Recreation
Rehabilitation
Screening
Sex education
Sharps disposal

Safe Disposal of Used Needles and Syringes in the Community: Update on AMA Activities (A-02) Full text

Safe Community Syringe Disposal: Understanding the Barriers and Creating Solutions - Summary report of meeting sponsored by the American Medical Association, the Centers for Disease Control and Prevention, the American Association for Diabetes Educators, the American Pharmaceutical Association, and the Academy for Educational Development, Washington, DC, January 29-30, 2001. Full text

Smallpox

Smallpox: A Scientific Update (I-02) Full text

 

Smoking - see Alcohol/nicotine/other drug abuse

Smoking - see Alcohol/nicotine/other drug abuse

Special populations
Stem cells
Tuberculosis
Violence
Vital statistics
Women's health